Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Probable rRNA-processing protein EBP2 (EBNA1BP2) is a conserved nucleolar protein required for the processing of 27S pre-rRNA and the biogenesis of the ribosomal large subunit, enabling RNA binding activity[4][5]. It localizes predominantly to the nucleolus and functions as a scaffold protein in rRNA processing and ribosome assembly[2][3]. EBNA1BP2 also interacts directly with Epstein–Barr virus (EBV) nuclear antigen 1 (EBNA1), mediating the tethering and faithful partitioning of EBV episomes during cell division, a function essential for latent EBV genome maintenance in host cells[1][2]. While it plays dual roles in normal ribosome biogenesis and viral episome segregation, EBNA1BP2 is not a classical therapeutic target such as a receptor or enzyme and currently has no known drug interactions or biomarker/safety concern associations[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable rRNA-processing protein EBP2 (EBNA1BP2).